One step synthesis of 6-oxo-cholestan-3β,5α-diol

Biochemical and Biophysical Research Communications

Volumn 446, Issue 3, 2014, Pages 782-785

  Voisin, Maud ^a,b   Silvente Poirot, Sandrine ^a,b   Poirot, Marc ^a,b  

^a INSTITUT CLAUDIUS REGAUD   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Cancer; Cholestanetriol; OCDO; Oxysterols; Radiolabelled

Indexed keywords

CARBON 14; CHOLESTANE DERIVATIVE; CHOLESTEROL DERIVATIVE; IODINE DERIVATIVE; PERIODATE; STEROL DERIVATIVE;

ACETYLATION; ARTICLE; AUTORADIOGRAPHY; BREAST CANCER; CENTRIFUGATION; CHOLESTEROL SYNTHESIS; DEACETYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; TUMOR CELL LINE;

CANCER; CHOLESTANETRIOL; OCDO; OXYSTEROLS; RADIOLABELLED;

CHEMISTRY TECHNIQUES, SYNTHETIC; CHOLESTEROL; OXIDATION-REDUCTION;

EID: 84898797442     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.138     Document Type: Article

References (23)

1. L. Raccosta, R. Fontana, D. Maggioni, C. Lanterna, E.J. Villablanca, and A. Paniccia et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils J. Exp. Med. 210 2013 1711 1728
2. M. Poirot, and S. Silvente-Poirot Oxysterols and related sterols: implications in pharmacology and pathophysiology Biochem. Pharmacol. 86 2013 1 2
3. E.R. Nelson, S.E. Wardell, J.S. Jasper, S. Park, S. Suchindran, and M.K. Howe et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology Science 342 2013 1094 1098
4. P. de Medina, M.R. Paillasse, G. Segala, M. Voisin, L. Mhamdi, and F. Dalenc et al. Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties Nat. Commun. 4 2013 1840
5. S. Silvente-Poirot, and M. Poirot Cholesterol metabolism and cancer: the good, the bad and the ugly Curr. Opin. Pharmacol. 12 2012 673 676
6. A. Sukhanova, A. Gorin, I.G. Serebriiskii, L. Gabitova, H. Zheng, and D. Restifo et al. Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation Cancer Discov. 3 2013 96 111
7. L. Gabitova, A. Gorin, and I. Astsaturov Molecular pathways: sterols and receptor signaling in cancer Clin. Cancer Res. 20 2014 28 34
8. P. de Medina, M.R. Paillasse, G. Segala, M. Poirot, and S. Silvente-Poirot Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands Proc. Natl. Acad. Sci. USA 107 2010 13520 13525
9. S. Silvente-Poirot, and M. Poirot Cholesterol epoxide hydrolase and cancer Curr. Opin. Pharmacol. 12 2012 696 703
10. P. de Medina, M.R. Paillasse, B. Payre, S. Silvente-Poirot, and M. Poirot Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases J. Med. Chem. 52 2009 7765 7777
11. S.A. Khalifa, P. de Medina, A. Erlandsson, H. Elseedi, S. Silvente-Poirot, and M. Poirot The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells Biochem. Biophys. Res. Commun. 446 2014 680 685 10.1016/j.bbrc.2013.12.134
12. B. Sola, M. Poirot, P. de Medina, S. Bustany, V. Marsaud, and S. Sivente-Poirot et al. Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism Oncotarget 4 2013 911 922
13. G. Segala, P. de Medina, L. Iuliano, C. Zerbinati, M.R. Paillasse, and E. Noguer et al. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells Biochem. Pharmacol. 86 2013 175 189
14. J. de Weille, C. Fabre, and N. Bakalara Oxysterols in cancer cell proliferation and death Biochem. Pharmacol. 86 2013 154 160
15. M. Poirot, S. Silvente-Poirot, and R.R. Weichselbaum Cholesterol metabolism and resistance to tamoxifen Curr. Opin. Pharmacol. 12 2012 683 689
16. Y.W. Cheng, J.J. Kang, Y.L. Shih, Y.L. Lo, and C.F. Wang Cholesterol-3-beta, 5-alpha, 6-beta-triol induced genotoxicity through reactive oxygen species formation Food Chem. Toxicol. 43 2005 617 622
17. P. de Medina, M. Paillasse, M. Poirot, S. Silvente-Poirot. Methods for determining the oncogenic condition of cell, uses thereof, and methods for treating cancer. US Patent 2012; US2012100124.
18. O. Kucuk, J. Stoner-Picking, S. Yachnin, L.I. Gordon, R.M. Williams, and L.J. Lis et al. Inhibition of NK cell-mediated cytotoxicity by oxysterols Cell Immunol. 139 1992 541 549
19. R.A. Streuli, J. Chung, A.M. Scanu, and S. Yachnin Inhibition of human lymphocyte E-rosette formation by oxygenated sterols J. Immunol. 123 1979 2897 2902
20. O. Kucuk, J. Stoner-Picking, S. Yachnin, L.I. Gordon, R.M. Williams, and L.J. Lis et al. Inhibition of cytolytic T lymphocyte activity by oxysterols Lipids 29 1994 657 660
21. R.P. Graber, J.C.S. Snoddy, H.B. Arnold, and N.L. Wendler Notes - the oxidation of cholesterol by periodic acid J. Org. Chem. 21 1956 1517 1518
22. K. Zhao, Y. Wang, and L. Han 4,5-Epoxycholestane-3,6-diols: templates for generating the full set of eight cholestane-3,5,6-triol stereoisomers in multigram scales, but not for a cholestane-3,4,6-triol Steroids 72 2007 95 104
23. L.F. Fieser, and S. Rajagopalan Selective oxidation with N-Bromosuccinimide. II. Cholestane-3beta,5alpha,6beta-triol J. Am. Chem. Soc. 71 1949 3938 3941